Ben Yong bought BBOT
March 10, 2026 · Form 4 insider transaction
Ben Yong bought 46,670 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,670
Price
$0.00
Total value
N/A
InsiderBen Yong
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 10, 2026
Filing dateMarch 12, 2026
Shares owned after46,670
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a period of four years from January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. The RSUs will be settled in shares of Common Stock upon vesting.